Back to search

Article

Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study

2022-12-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background and Objective:</bold> Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune inflammatory disease of the central nervous system that affects multiple generations. Long-term immunosuppressive treatments, especially with prednisolone, for middle-aged and older patients with NMOSD can lead to various complications. In this study, we aimed to evaluate the effic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62f268e3-d1ed-524d-ad47-6f5a628a4b3e
DOI
10.21203/rs.3.rs-2212412/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort studyDOI 10.21203/rs.3.rs-2212412/v1
Myelitis-Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late-Onset Neuromyelitis Optica Spectrum Disorders.Semantic proximity
Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients.Semantic proximity
Unmet Needs in the Care of Patients with Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: Insights from GermanySemantic proximity
Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil.Semantic proximity
Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab.Semantic proximity
Efficacy and safety of different oral prednisone tapering course in adult anti-NMDAR encephalitis: A multicenter prospective cohort studySemantic proximity
Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report.Semantic proximity
Systematic Review and Meta-analysis of Eculizumab, Inebilizumab, Tocilizumab, and Satralizumab for Neuromyelitis OpticaSemantic proximity
Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.Semantic proximity
Disease Modifying Therapies and COVID-19 Severity in Multiple SclerosisSemantic proximity
Switching from Complement Inhibitors in AQP4-IgG–Positive NMOSD: Clinical Characteristics, an Operational “Cluster Phase,” and Potential Strategies to Prevent Therapeutic GapsSemantic proximity
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.Semantic proximity
Select a neighboring publication to make it the new centre.